Top 20 of Death, Sudden, Cardiac

Article title # Publications/# Citations

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

2005: Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators; JAnderson; GHBardy; RBoineau; NClapp-Channing; LDDavidson-Ray; MDomanski; DPFishbein; ... ESFraulo; JHIp; GJohnson; KLLee; RMLuceri; DBMark; SEMcNulty; DLPacker; JEPoole; CTroutman;

310

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

2003: Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators; RBittman; MGatlin; SHurley; JKleiman; FMartinez; JNeaton; BPitt; ... WRemme; BRoniker; FZannad;

269

Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

2000: APBurke; AFarb; FDKolodgie; SMSchwartz; RVirmani;

241

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.

1998: JTBigger; MTLa Rovere; FIMarcus; AMortara; PJSchwartz;

193

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

1999:

191

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

2003: MAikawa; GAssmann; JJBadimón; RBahr; CBallantyne; CRBecker; EBoerwinkle; ABurke; ... SWCasscells; JHChesebro; AColombo; CLDe Korte; JDemirovic; HDrexler; EFalk; AFarb; DPFaxon; ZFayad; PJFitzgerald; ZSGalis; PGreenland; SMGrundy; GKHansson; WInsull; CJackson; IKJang; KEJuhani Airaksinen; SKaul; WKoenig; PLibby; SLitovsky; RALodder; MMadjid; KMarch; RMehran; PMoreno; JEMuller; MNaghavi; MNavab; GPasterkamp; SGPriori; PRaggi; MDRekhter; PMRidker; JRumberger; RSSchwartz; PWSerruys; PKShah; DSSiscovick; CStefanadis; PHStone; RVirmani; RVogel; SWaxman; JTWillerson; CYuan; AZarrabi; DPZipes;

189

Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

2001: AHBeggs; RBloise; GBreithardt; PBrink; CCorbett; VCorfield; PCoumel; IDenjoy; ... PGuicheney; WHaverkamp; MTKeating; MHLehmann; AJMoss; CNapolitano; SGPriori; JLRobinson; ESchulze-Bahr; KSchwartz; PJSchwartz; CSpazzolini; KWTimothy; LToivonen; JATowbin; GMVincent; DWattanasirichaigoon; AAWilde; WZareba;

176

Pathology of the vulnerable plaque.

2006: APBurke; AFarb; FDKolodgie; RVirmani;

171

Sudden cardiac death in the United States, 1989 to 1998.

2001: JBCroft; WHGiles; GAMensah; ZJZheng;

170

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.

2003: MEAli; VBennett; KWDilly; WHDubell; DEscande; AOGramolini; SGuatimosim; KHaurogné; ... FKyndt; Hle Marec; WJLederer; PJMohler; TBRogers; JJSchott; LSSong;

168

Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.

1992: JBrugada; PBrugada;

168

Homocysteine lowering and cardiovascular events after acute myocardial infarction.

2006: NORVIT Trial Investigators; EArnesen; KHBønaa; INjølstad; JENordrehaug; KRasmussen; HSchirmer; TSteigen; ... ATverdal; PMUeland; HWang;

165

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

2007: European Association for the Study of Diabetes (EASD); Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); MBartnik; MBertrand; JBetteridge; JJBlanc; ABudaj; JCamm; ... BCharbonnel; FCosentino; MJde Boer; VDean; JDeckers; JWDeckers; KDickstein; EErdmann; EFerrannini; AFlyvbjerg; HGohlke; IGraham; BJonsson; JRJuanatey; MLaakso; JLekakis; PLindgren; KMalmberg; KMcGregor; MMetra; PFMonteiro; JMorais; JÖstergren; AOsterspey; KParhofer; SPriori; SGPriori; KPyörälä; QQiao; IRaz; LRydén; GSchernthaner; EStandl; MStramba-Badiale; JTamargo; IThrainsdottir; JTuomilehto; GVan den Berghe; IVanhorebeek; MVolpe; DWood; JLZamorano;

164

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.

2006: NLKeating; AJO'Malley; MRSmith;

161

Sudden cardiac death.

1998: HJWellens; DPZipes;

152

Clinical assessment incorporating a personal genome.

2010: RBAltman; EAAshley; DSBerlin; AJButte; RChen; MFChou; GMChurch; FEDewey; ... JTDudley; LGong; HTGreely; JMHebert; LMHodges; LHudgins; TEKlein; JWKnowles; AAMorgan; NFNeff; KEOrmond; APavlovic; DPushkarev; SRQuake; AMRosenbaum; HSagreiya; KSangkuhl; JVThakuria; CFThorn; RWhaley; MTWheeler; MWoon; AWZaranek;

149

FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death.

2003: JMD'Armiento; SGuatimosim; FHuang; WJLederer; SELehnart; ARMarks; MMemmi; PJMohler; ... CNapolitano; SGPriori; SRReiken; NRosemblit; LSSong; JSun; JAVest; XHWehrens;

148

A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.

1999: AEBuxton; JDFisher; GHafley; MEJosephson; KLLee; ENPrystowsky;

137

Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43.

2001: JChen; KRChien; GIFishman; DEGutstein; GEMorley; MDSchneider; HStuhlmann; HTamaddon; DVaidya;

129

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

2006: AFarb; AVFinn; HKGold; MJoner; FDKolodgie; RKutys; ELadich; EKMont; KSkorija; RVirmani;

126